Market Overview:
The global meropenem trihydrate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for meropenem trihydrate as an antibiotic drug, and growing investments by pharmaceutical companies in research and development (R&D) activities. Based on type, the global meropenem trihydrate market can be segmented into purity greater than or equal to 98% and purity greater than or equal to 99%. The purity greater than or equal to 98% segment is expected to account for a larger share of the global market in 2018. This segment is projected to grow at a CAGR of xx% during the forecast period. Based on application, the global meropenem trihydrate market can be divided into meropenem trihydrate injection and other applications. The injection application segment is expected to account for a larger share of the global market in 2018. This segment is projected grow at a CAGR of xx %duringthe forecastperiod .
Product Definition:
Meropenem Trihydrate is an antibiotic that is used to treat a variety of infections. It works by killing the bacteria that are causing the infection.
PurityGreater than or equal to98%:
The global Meropenem Trihydrate (PHT) market size was valued at USD 5.0 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Increasing demand for advanced drug formulations, rising prevalence of multidrug-resistant bacterial infections, and growing investments by key players are some major factors driving the growth of this market globally.
PurityGreater than or equal to99%:
Purity Greater than or equal to 99% is a crystalline form of meropenem, which has been the subject of intense research for over two decades. It was first synthesized by Dr. Robert Langer in his laboratory at the Massachusetts Institute of Technology (MIT) in Cambridge, U.S., back in 1994 and 1995 respectively.
Application Insights:
Meropenem trihydrate injection was the largest revenue-generating segment in 2017. This is due to its high preference and adoption as a drug for treatment of multidrug-resistant tuberculosis, which is highly prevalent in countries including China, India and Bangladesh. According to WHO, around 10 million people were diagnosed with TB worldwide and approximately 1.6 million died from the disease in 2016. Meropenem trihydrate injections are also used for other indications such as skin infections caused by Staphylococcus aureus or methicillin-resistant S. aureus (MRSA).
Regional Analysis:
North America dominated the global meropenem trihydrate market in 2017 with a revenue share of over 40%. The rising incidence of multi-drug resistant tuberculosis is one of the major factors responsible for this dominance. In addition, increasing government initiatives and programs to combat drug-resistant infections are expected to drive growth during the forecast period. For instance, in October 2016, FDA approved Moxifloxacin Hydrochloride Extended-Release Tablets (400 mg) for extended treatment of multidrug resistant tuberculosis infection.
Asia Pacific is anticipated to be the fastest growing region during the forecast period owing to high prevalence rates coupled with increasing government spending on healthcare infrastructure development and expansion.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the Meropenem Trihydrate market. This is because Meropenem Trihydrate is an effective antibiotic against a wide range of bacteria, including resistant strains.
- Rising demand for injectable drugs: The growing demand for injectable drugs is another key factor driving the growth of the Meropenem Trihydrate market. This is because injectable drugs are considered to be more efficacious than oral medications in treating various infections.
- Growing number of meropenem-resistant bacteria: The growing number of meropenem-resistant bacteria is also fueling the growth of the Meropenem Trihydrate market as it has led to an increase in demand for alternative antibiotics such as meropenem trihydrate.
- Technological advancements in drug development: Technological advancements in drug development are also aiding in the growth and expansion of this market, as they have enabled manufacturers to develop newer and more effective antibiotics such as merope
Scope Of The Report
Report Attributes
Report Details
Report Title
Meropenem Trihydrate Market Research Report
By Type
PurityGreater than or equal to98%, PurityGreater than or equal to99%
By Application
Meropenem Trihydrate Injection, Other
By Companies
HangZhou HuiSheng Biotech Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Daewoong Chemical, Qilu Pharmaceutical, Micro Orgo Chem, Zhuhai United Laboratories, Huazhong Pharmaceutical, Zhejiang Botai Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Meropenem Trihydrate Market Report Segments:
The global Meropenem Trihydrate market is segmented on the basis of:
Types
PurityGreater than or equal to98%, PurityGreater than or equal to99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Meropenem Trihydrate Injection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HangZhou HuiSheng Biotech Pharmaceutical
- Zhejiang Jiuzhou Pharmaceutical
- Daewoong Chemical
- Qilu Pharmaceutical
- Micro Orgo Chem
- Zhuhai United Laboratories
- Huazhong Pharmaceutical
- Zhejiang Botai Chemical
Highlights of The Meropenem Trihydrate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PurityGreater than or equal to98%
- PurityGreater than or equal to99%
- By Application:
- Meropenem Trihydrate Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meropenem Trihydrate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meropenem Trihydrate is a medication used to treat serious infections, including pneumonia. It works by killing the bacteria that is causing the infection. Meropenem Trihydrate can be taken by mouth or intravenously.
Some of the key players operating in the meropenem trihydrate market are HangZhou HuiSheng Biotech Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Daewoong Chemical, Qilu Pharmaceutical, Micro Orgo Chem, Zhuhai United Laboratories, Huazhong Pharmaceutical, Zhejiang Botai Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Meropenem Trihydrate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Meropenem Trihydrate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Meropenem Trihydrate Market - Supply Chain
4.5. Global Meropenem Trihydrate Market Forecast
4.5.1. Meropenem Trihydrate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Meropenem Trihydrate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Meropenem Trihydrate Market Absolute $ Opportunity
5. Global Meropenem Trihydrate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Meropenem Trihydrate Market Size and Volume Forecast by Type
5.3.1. PurityGreater than or equal to98%
5.3.2. PurityGreater than or equal to99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Meropenem Trihydrate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Meropenem Trihydrate Market Size and Volume Forecast by Application
6.3.1. Meropenem Trihydrate Injection
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Meropenem Trihydrate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Meropenem Trihydrate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Meropenem Trihydrate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Meropenem Trihydrate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Meropenem Trihydrate Demand Share Forecast, 2019-2026
9. North America Meropenem Trihydrate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Meropenem Trihydrate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Meropenem Trihydrate Market Size and Volume Forecast by Application
9.4.1. Meropenem Trihydrate Injection
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Meropenem Trihydrate Market Size and Volume Forecast by Type
9.7.1. PurityGreater than or equal to98%
9.7.2. PurityGreater than or equal to99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Meropenem Trihydrate Demand Share Forecast, 2019-2026
10. Latin America Meropenem Trihydrate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Meropenem Trihydrate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Meropenem Trihydrate Market Size and Volume Forecast by Application
10.4.1. Meropenem Trihydrate Injection
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Meropenem Trihydrate Market Size and Volume Forecast by Type
10.7.1. PurityGreater than or equal to98%
10.7.2. PurityGreater than or equal to99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Meropenem Trihydrate Demand Share Forecast, 2019-2026
11. Europe Meropenem Trihydrate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Meropenem Trihydrate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Meropenem Trihydrate Market Size and Volume Forecast by Application
11.4.1. Meropenem Trihydrate Injection
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Meropenem Trihydrate Market Size and Volume Forecast by Type
11.7.1. PurityGreater than or equal to98%
11.7.2. PurityGreater than or equal to99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Meropenem Trihydrate Demand Share, 2019-2026
12. Asia Pacific Meropenem Trihydrate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Meropenem Trihydrate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Meropenem Trihydrate Market Size and Volume Forecast by Application
12.4.1. Meropenem Trihydrate Injection
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Meropenem Trihydrate Market Size and Volume Forecast by Type
12.7.1. PurityGreater than or equal to98%
12.7.2. PurityGreater than or equal to99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Meropenem Trihydrate Demand Share, 2019-2026
13. Middle East & Africa Meropenem Trihydrate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Meropenem Trihydrate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Meropenem Trihydrate Market Size and Volume Forecast by Application
13.4.1. Meropenem Trihydrate Injection
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Meropenem Trihydrate Market Size and Volume Forecast by Type
13.7.1. PurityGreater than or equal to98%
13.7.2. PurityGreater than or equal to99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Meropenem Trihydrate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Meropenem Trihydrate Market: Market Share Analysis
14.2. Meropenem Trihydrate Distributors and Customers
14.3. Meropenem Trihydrate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. HangZhou HuiSheng Biotech Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhejiang Jiuzhou Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daewoong Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qilu Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Micro Orgo Chem
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zhuhai United Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Huazhong Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhejiang Botai Chemical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
